Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Current Hypertension Reports
Erschienen in: Current Hypertension Reports 4/2015

01.04.2015 | Hypertension and Obesity (E Reisin, Section Editor)

Obesity and Left Ventricular Hypertrophy: The Hypertension Connection

verfasst von: Angela J. Woodiwiss, Gavin R. Norton

Erschienen in: Current Hypertension Reports | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

The detection of left ventricular hypertrophy (LVH) is recommended for risk prediction, and changes in LV geometry may provide further prognostic information. Obesity is a major determinant of LVH, but the approach to LVH detection in obese hypertensives remains a challenge. In the present review, we discuss evidence leading to the recent acceptance of the use of LV mass indexed to height2.7 or height1.7 rather than body surface area, for LVH detection and its regression in obesity. We also review recent findings which indicate that obesity-induced LVH may be associated with concentric LV remodeling, and hence, that the presence of concentric LVH in obesity should not be assumed to indicate a cause of LVH other than obesity. We also discuss recent evidence for obesity and blood pressure producing additive and interactive effects on LV mass, and hence, that weight loss and blood pressure reduction are required to achieve appropriate regression.
Literatur
1.
Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334–41.CrossRefPubMed
2.
Verdecchia P, Angeli F, Borgioni C, et al. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens. 2003;16:895–9.CrossRefPubMed
3.
Gerdts E, Cramariuc D, de Simone G, et al. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr. 2008;9:809–15.CrossRefPubMed
4.
Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995;25:879–84.CrossRefPubMed
5.
Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J. 2013;34:2159–219.CrossRefPubMed
6.
Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377:557–67.CrossRefPubMed
7.
Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis. 2014;56:391–400.CrossRefPubMed
8.
de Simone G, Izzo R, De Luca N, Gerdts E. Left ventricular geometry in obesity: is it what we expect? Nutr Metab Cardiovasc Dis. 2013;23:905–12.CrossRefPubMed
9.••
Chirinos JA, Segers P, De Buyzere ML, et al. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension. 2010;56:91–8. This paper introduced the allometric exponent of 1.7 which eliminated the residual negative relationship between LVM indexed to height 2.7 and height. Sex- and ethnic-specific thresholds of LVM indexed to body surface area and height 1.7 , as well as comparisons of the prognostic values of LVM indexed to body surface area, height 2.7 and height 1.7 are provided.
10.
Sibiya MJ, Norton GR, Hodson B, et al. Gender-specific contribution of aortic augmentation index to variations in left ventricular mass index in a community sample of African ancestry. Hypertens Res. 2014;37:1021–7.CrossRefPubMed
11.
Booysen HL, Woodiwiss AJ, Sibiya MJ et al. Indexes of aortic pressure augmentation markedly underestimate the contribution of reflected waves toward variations in aortic pressure and left ventricular mass. Hypertension. 2015 (in press).
12.
de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20:1251–60.CrossRefPubMed
13.
de Simone G, Kizer JR, Chinali M, et al. Normalization for body size and population—attributable risk of left ventricular hypertrophy. The Strong Heart Study. Am J Hypertens. 2005;18:191–6.CrossRefPubMed
14.
Paajanen TA, Oksala NK, Kuukasjarvi P, et al. Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis. Eur Heart J. 2012;31:1802–9.CrossRef
15.•
de Simone G, Devereux RB. Method errors or unexplained biological information? Hypertension. 2010;56:e177–8. This letter compared the prognostic values of LVM indexed to body surface area, height 2.7 and height 1.7 and emphasized the importance of population attributable risk.
16.
Poppe KK, Edgerton Bachmann M, Triggs CM, et al. Geographic variation in left ventricular mass and mass index: a systematic review. J Hum Hypertens. 2012;26:420–9.CrossRefPubMed
17.
Lang RM, Bierig M, Devereux R, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;8:1440–63.CrossRef
18.
Aurigemma GP, de Simone G, Fitzgibbons TP. Cardiac remodelling in obesity. Circ Cardiovasc Imaging. 2013;6:142–52.CrossRefPubMed
19.
Messerli FH, Sundgaard-Riise K, Reisin E, et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med. 1983;99:757–61.CrossRefPubMed
20.
Bastien M, Poirier P, Lemieux I, Despres J-P. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369–81.CrossRefPubMed
21.
Gerdts E, de Simone G, Lund BP, et al. Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. Nutr Metab Cardiovasc Dis. 2013;23:122–9.CrossRefPubMed
22.
Woodiwiss AJ, Libhaber CD, Majane OHI, et al. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens. 2008;21:1144–52.CrossRefPubMed
23.••
Turkbey EB, McClelland RL, Kronmal RA, et al. The impact of obesity on the left ventricle: the multi-ethnic study of atherosclerosis (MESA). JACC Cardiovasc Imaging. 2010;3:266–74. This large study (over 5000 participants) assessed the impact of obesity on left ventricular mass and geometry using cardiac magnetic resonance imaging (MRI), hence avoiding the possibility of poor echocardiographic windows in obesity.CrossRefPubMedCentralPubMed
24.••
Neeland IJ, Gupta S, Ayers CR, et al. Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging. 2013;6:800–7. In this large study (2710 participants) dual energy x-ray absorptiometry and magnetic resonance imaging were used to assess fat distribution. Visceral adipose tissue (central obesity) was shown to be associated with concentric LV remodelling; whereas lower body subcutaneous fat was associated with eccentric LV remodelling.CrossRefPubMedCentralPubMed
25.
Kardassis D, Bech-Hanssen O, Schonander M, et al. The influence of body composition, fat distribution, and sustained weight loss on left ventricular mass and geometry in obesity. Obesity. 2012;20:605–11.CrossRefPubMed
26.•
Cuspidi C, Rescaldani M, Sala C, Grassi G. Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens. 2014;32:16–25. This is a meta-analysis of echocardiographic studies showing that although obesity is largely associated with eccentric LV remodelling, a significant proportion of concentric LV remodelling was also observed. It is important to note that no adjustments for either the presence of hypertension or blood pressure were made in these studies.CrossRefPubMed
27.
Khouri MG, Peshock RM, Ayers CR, et al. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study. Circ Cardiovasc Imaging. 2010;3:129–31.CrossRef
28.
Owan T, Avelar E, Morley K, et al. Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study. J Am Coll Cardiol. 2011;57:732–9.CrossRefPubMedCentralPubMed
29.••
Hsuan C-F, Huang C-K, Lin J-W, et al. The effect of surgical weight reduction on left ventricular structure and function in severe obesity. Obesity. 2010;18:1188–93. An intervention study assessing changes in LV mass and geometry 3 months after bariatric surgery, which showed that blood pressure reduction was the most important determinant of the regression of LV mass and relative wall thickness.CrossRefPubMed
30.
Luaces M, Cachofeiro V, Najar B+G-M-A, et al. Anatomical and functional alterations of the heart in morbid obesity. Changes after bariatric surgery. Rev Esp Cardiol. 2012;65:14–21.CrossRefPubMed
31.•
Cuspidi C, Rescaldami M, Tadic M, et al. Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis. Am J Hypertens. 2014;27:146–56. A meta-analysis of 23 bariatric surgery studies showing that a significant decrease in relative wall thickness (and hence a less concentric LV geometry) occurred together with reductions in LVM and LVM indexed to height 2.7 .
32.
de las Fuentes L, Waggoner AD, Mohammed S, et al. Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J Am Coll Cardiol. 2009;54:2376–86.CrossRefPubMedCentralPubMed
33.
Rider OJ, Lewandowski A, Nethononda R, et al. Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging. Eur Heart J. 2013;34:292–9.CrossRefPubMedCentralPubMed
34.
de Gonzalez BA, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2011;363:2211–9.CrossRef
35.
Palatini P, Saladini F, Mos L, et al. Obesity is a strong determinant of hypertensive target organ damage in young-to-middle-age patients. Int J Obesity. 2013;37:224–9.CrossRef
36.•
Gidding SS, Liu K, Colangelo LA, et al. Longitudinal determinants of left ventricular mass and geometry: the coronary risk development in young adults (CARDIA) study. Circ Cardiovasc Imaging. 2013;6:769–75. This is a large (2426 participants) longitudinal study which identified the determinants of increases in LV mass and relative wall thickness over 20 years.CrossRefPubMed
37.
Avelar E, Cloward TV, Walker JM, et al. Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension. 2007;49:34–9.CrossRefPubMed
38.
Norton GR, Majane OHI, Libhaber E, et al. The relationship between blood pressure and left ventricular mass index depends on an excess adiposity. J Hypertens. 2009;27:1873–83.CrossRefPubMed
39.•
Simone G, Devereux RB, Izzo R, et al. Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. J Am Heart Assoc. 2013;2:e000144. This is a longitudinal study which assessed the predictors of LVM regression.CrossRefPubMedCentralPubMed
Metadaten
Titel
Obesity and Left Ventricular Hypertrophy: The Hypertension Connection
verfasst von
Angela J. Woodiwiss
Gavin R. Norton
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Current Hypertension Reports / Ausgabe 4/2015
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-015-0539-z

Weitere Artikel der Ausgabe 4/2015

Current Hypertension Reports 4/2015 Zur Ausgabe

Pediatric Hypertension (B Falkner, Section Editor)

The Relationship Between Currently Recommended Ambulatory Systolic Blood Pressure Measures and Left Ventricular Mass Index in Pediatric Hypertension

Hypertension and the Heart (SD Solomon and O Vardeny, Section Editors)

Coronary Heart Disease Risk Factors and Outcomes in the Twenty-First Century: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Guidelines/Clinical Trials/Meta-Analysis (JB Kostis, Section Editor)

Not Just Chlorthalidone: Evidence-Based, Single Tablet, Diuretic Alternatives to Hydrochlorothiazide for Hypertension

Antihypertensive Agents: Mechanisms of Drug Action (ME Ernst, Section Editor)

Personalizing the Diuretic Treatment of Hypertension: the Need for More Clinical and Research Attention

Blood Pressure Monitoring and Management (J Cockcroft, Section Editor)

MEthods of ASsessing blood pressUre: identifying thReshold and target valuEs (MeasureBP): A Review & Study Protocol

Blood Pressure Monitoring and Management (J Cockcroft, Section Editor)

The Role of Telemedicine in Hypertension Management: Focus on Blood Pressure Telemonitoring

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Prävention und Rehabilitation in der Kardiologie | Nachrichten

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Demenz | Nachrichten

Demenzkranke durch Antipsychotika vielfach gefährdet
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise